Physician profile
John D Thompson
NPI 1578624342
$2,479.66
in general payments reported to CMS, 2019-2025
27 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $220 · 2021: $373 · 2022: $450 · 2023: $478 · 2024: $232 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $263.96 | 2020-2025 | |
| Boston Scientific Corporation | $256.13 | 2019-2025 | Versapulse Powersuite 100w |
| Sumitomo Pharma America, INC. | $253.33 | 2023-2025 | Gemtesa, Orgovyx |
| Myovant Sciences INC. | $228.37 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $177.87 | 2021-2024 | Prolaris |
| Endo Pharmaceuticals INC. | $175.03 | 2019-2024 | Xiaflex, Aveed |
| Coloplast Corp | $166.50 | 2019-2025 | Titan |
| Teleflex LLC | $164.28 | 2021-2025 | Urolift |
| Urovant Sciences INC | $108.58 | 2021-2022 | |
| Astellas Pharma US INC | $95.92 | 2019-2025 | Xtandi |
| Zimmer Biomet Holdings, INC. | $74.46 | 2021 | |
| Janssen Biotech, INC. | $58.41 | 2019 | |
| 180 Medical, INC. | $53.88 | 2019-2024 | |
| Laborie Medical Technologies Corp. | $50.70 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $47.75 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $43.07 | 2020-2022 | |
| Abc Home Medical Supply, INC. | $41.45 | 2025 | |
| Telix Pharmaceuticals | $36.53 | 2022-2023 | Illuccix |
| Neotract INC. | $29.85 | 2019 | |
| Procept Biorobotics Corporation | $27.43 | 2023 | Aquabeam Robotic System |
| Olympus America INC. | $23.50 | 2023 | Itind System |
| Axonics, INC. | $20.74 | 2021 | |
| Genzyme Corporation | $19.41 | 2019 | |
| Allergan, INC. | $17.58 | 2019 | |
| Duchesnay USA Incorporated | $15.57 | 2019 | |
| Dentsply Ih INC. | $15.02 | 2020 | |
| Antares Pharma, INC. | $14.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.